| Literature DB >> 18602328 |
Rita Gonçalves1, Simon R Platt, Francisco J Llabrés-Díaz, Katherine H Rogers, Alberta de Stefani, Lara A Matiasek, Vicki J Adams.
Abstract
Medical records of 92 cats presented with clinical signs of spinal cord disease, which had undergone magnetic resonance imaging (MRI), were reviewed. The cats were grouped into seven categories based upon the diagnosis suggested by results of MRI, cerebrospinal fluid analysis and other diagnostic procedures: neoplastic (n=25), inflammatory or infectious (n=13), traumatic (n=8), vascular (n=6), degenerative (n=5), anomalous (n=3) and those with an unremarkable MRI (n=32). There were two independent predictors of abnormal MRI findings: severity of clinical signs and presence of spinal pain. Abnormal MRI findings and speed of onset of disease were significantly associated with survival. For the 32 cats with unremarkable MRI findings, only nine died due to spinal disease and, therefore, the median survival time (MST) was not reached (lower 95% confidence interval (CI)=970 days). For the 60 cats with abnormal MRI findings, 37 died due to their disease and the MST was 138 days (95% CI: 7-807).Entities:
Mesh:
Year: 2008 PMID: 18602328 PMCID: PMC7130086 DOI: 10.1016/j.jfms.2008.05.001
Source DB: PubMed Journal: J Feline Med Surg ISSN: 1098-612X Impact factor: 2.015
Clinical characteristics of 92 cases of spinal cord disease in cats
| Clinical characteristic | Number | % |
|---|---|---|
| Speed of onset of clinical signs | ||
| Peracute, <12 h | 24 | 26.1 |
| Acute, 12–48 h | 25 | 27.2 |
| Chronic, >48 h | 43 | 46.7 |
| Neurological score | ||
| 1 = Spinal pain only | 6 | 6.5 |
| 2 = Ataxia ± spinal pain | 22 | 23.9 |
| 3 = Ambulatory paresis ± spinal pain | 42 | 45.7 |
| 4 = Non-ambulatory paresis ± spinal pain | 10 | 10.9 |
| 5 = Paralysis with intact nociception ± spinal pain | 9 | 9.8 |
| 6 = Paralysis with loss of nociception ± spinal pain | 3 | 3.3 |
| CSF analysis – performed in 53 cats | ||
| Normal | 26 | 49.1 |
| Albuminocytological dissociation | 4 | 7.5 |
| Pleocytosis | 23 | 43.4 |
| Cell count 5–50 cells/μl | 17 | 73.9 |
| Cell count 50–500 cells/μl | 6 | 26.1 |
Fig 1Flowchart showing clinical characteristics and outcome for the 92 cases. ‡At date of censor (15 November 2006), *lost to follow-up after first interview (31 May 2004), and †one cat with polyneuritis lost to follow-up 197 days after diagnosis.
MRI findings in 60 cases with abnormalities detected on MRI
| Number | % | |
|---|---|---|
| Spinal cord segment affected | ||
| C1–C5 | 14 | 24 |
| C6–T2 | 5 | 8 |
| T3–L3 | 25 | 42 |
| L4–L6 | 8 | 13 |
| L7–S3 | 8 | 13 |
| Location of lesion | ||
| Paraspinal | 5 | 8 |
| Extradural | 30 | 50 |
| Intradural extramedullary | 5 | 8 |
| Intradural intramedullary | 20 | 34 |
| Effect of lesion on spinal cord | ||
| No spinal cord changes | 5 | 8 |
| Compression | 22 | 37 |
| Swelling | 1 | 2 |
| MRI signal alteration | 9 | 15 |
| Compression and signal alteration | 6 | 10 |
| Swelling and signal alteration | 15 | 25 |
| Compression, swelling and signal alteration | 2 | 3 |
Disease categories, presumptive diagnosis and age at diagnosis for 92 cats with clinical signs of spinal cord disease
| Disease category and presumptive diagnosis | Diagnosis confirmed | Number | Age at diagnosis | ||
|---|---|---|---|---|---|
| Median | Minimum | Maximum | |||
| No abnormalities on MRI, | 4.7 | 0.3 | 13.6 | ||
| Polymyositis | 1HP | 1 | 10 | 10 | 10 |
| Polyneuropathy | 1HP | 1 | 8.7 | 8.7 | 8.7 |
| Degenerative myelopathy | 1PM | 1 | 2.1 | 2.1 | 2.1 |
| No final diagnosis, abnormal CSF only | 0 | 11 | 4.5 | 0.3 | 11.7 |
| No final diagnosis, normal CSF | 0 | 13 | 5 | 1.5 | 13.6 |
| No final diagnosis, no CSF analysis | 0 | 5 | 4 | 2.5 | 6 |
| Neoplasia, | 8 | 0.7 | 18 | ||
| Soft tissue lymphoma | 1HP, 1Cyt, 2PM | 4 | 6.4 | 3 | 18 |
| Intramedullary lymphoma | 1HP, 1Cyt, 1PM | 3 | 6 | 2 | 7 |
| Soft tissue sarcomas | 2HP, 1Cyt | 3 | 7.5 | 4 | 15 |
| Nerve root tumour | 1HP, 1Cyt | 3 | 8 | 7.6 | 11.5 |
| Meningioma | 1HP | 2 | 7.8 | 7.6 | 8 |
| Vertebral body tumour | 1HP, 1PM | 2 | 11 | 10 | 12 |
| Unknown neoplasia | 1Cyt | 8 | 9.5 | 0.75 | 12 |
| Inflammatory/infectious, | 6 | 0.8 | 14 | ||
| Soft tissue abscess | 1Sx, 1PM | 5 | 6.5 | 3 | 11.75 |
| FIP | 2PCR | 2 | 2 | 0.8 | 3.3 |
| Discospondylitis | 0 | 2 | 9.5 | 5.5 | 14 |
| Myelitis of unknown aetiology | 0 | 2 | 8 | 3 | 13 |
| Toxoplasmosis | 1Ser | 1 | 6 | 6 | 6 |
| Brachial plexus neuritis | 0 | 1 | 9 | 9 | 9 |
| Traumatic, | 1 | 0.1 | 6.2 | ||
| Fractures | 3Sx | 4 | 0.9 | 0.1 | 6.2 |
| Luxation | 1Sx | 1 | 2 | 2 | 2 |
| Cord contusion | 0 | 3 | 4 | 1.5 | 8 |
| Vascular, | 9.1 | 5.8 | 16 | ||
| Ischaemic myelopathy | 0 | 6 | 9.1 | 5.8 | 16 |
| Degenerative, | 8 | 0.7 | 12 | ||
| Intervertebral disc disease | 1Sx | 5 | 8 | 0.75 | 12 |
| Anomalous, | 1.5 | 1.3 | 7.5 | ||
| Vertebral stenosis | 0 | 3 | 1.5 | 1.3 | 7.5 |
Diagnosis based on: Cyt = cytology from fine needle aspirate; HP = histopathology from biopsy; PM = post-mortem examination; Ser = serology; Sx = surgery.